CVS Health Preannounces Large Earnings Miss, But Analysts Stay Bullish On Long-Term Recovery
Portfolio Pulse from Priya Nigam
CVS Health Corp (NYSE:CVS) preannounced a significant earnings miss for Q3, leading to a drop in share prices. Despite this, analysts from Piper Sandler and Truist Securities maintain positive long-term outlooks, citing potential recovery under new CEO David Joyner.
October 21, 2024 | 3:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
CVS Health preannounced a Q3 earnings miss and withdrew full-year guidance, causing shares to drop. Analysts remain optimistic about long-term recovery under new CEO David Joyner.
CVS Health's preannouncement of a significant earnings miss and withdrawal of full-year guidance has led to a short-term negative impact on its stock price. However, analysts maintain a positive long-term outlook due to potential recovery under new leadership.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100